insight ci
ci stock vs thursday despit beat ep
rais guidanc investor unconvinc strength pbm
result earn in-lin ci miss analyst estim also
result see enough membership growth wish visibl better
ye overli concern
biggest concern seem pbm result
first full quarter ci/esrx result ci previous provid histor
pro-forma data new report segment today made model
challeng backdrop segment primarili pbm earn
estim also miss analyst project
consensu avail attempt recreat pro-forma result
estim earn would modest growth take
model reflect overhang transit
cost heavier invest merger earli month littl softer
us ci indic perform in-lin track meet outlook
investor get enough earn rais integr medic
integr medic segment primarili health insur busi earn
impress beat estim well-manag medic cost drove
out-performance vs estim assert strong result management
increas outlook less pyd think earli
reason posit take earli year integr stock
valuat think rais encourag
slow start enrol goal
medic enrol qoq suggest enrol
growth target lion share remain
happen around juli sept renew date select market book
fold commerci risk aso
keen focu smooth integr custom
note heavi repeat emphasi core busi focu uninterrupt
execut effort led strong retent across portfolio thu far
includ pharmaci renew visibl perhap ci littl less focus
new busi win may help explain slow enrol start
pt overhang reflect price-to-earnings
discount group averag reflect ci higher rel earn contribut
pbm carrier lower multipl risk util spike pbm integr
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
upsid ep target
esrx bring ci addit geograph breadth
capabl specialti cross-sel opportun
among best-in-class execut strong histori beat
rais
pbm retent cross-sel opportun
double-digit accret express script acquisit
mostli use repay debt modest share repurchas
achiev cost synergi
organ growth pbm
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
pleas see import disclosur inform page report
cigna earn summaryreport end decemb million except ep incom statementtot medic cost benefit pharmaci servic sell gener administr oper interest expens pre-tax incom incom continu less net incom loss attribut non-controlling sharehold net incom continu non- ep continu non-recur item realiz gains/ loss net dilut net incom dilut ep sharehold continu dilut share common sizeintegr medic bpspbm bpssell gener administr bpsoper bpstax bpssharehold net incom continu bpsmembership medicar govern integr medic servic total integr total medic segment financialsrevenueintegr group disabl adjust pre-tax incomeintegr group disabl reportedpercentag changediffer equiti research
pleas see import disclosur inform page report
cigna corpor one largest publicli trade health servic organ provid healthcar relat benefit major
compani busi offer workplac preferenti target employ interest provid
employe comprehens benefit plan compani five report segment includ healthcar disabl life
intern run-off reinsur includ corporate-own life insur healthcar segment offer insur
self-fund medic dental behavior vision prescript drug benefit plan disabl life segment provid long-
short-term disabl insur worker compens case manag accid specialti insur intern
segment offer life accid supplement healthcar servic busi individu select foreign market
compani form result merger connecticut gener life insur compani cg insur compani
north america ina corpor headquart locat philadelphia pennsylvania
pt ep discount group averag reflect ci higher rel earn contribut pbm
carrier lower multipl risk util spike pbm integr disrupt membership attrit regulatori risk
david windley cfa certifi view express research report accur reflect person view
subject secur subject compani also certifi part compens directli indirectli
relat specif recommend view express research report
david styblo cfa certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
pleas see import disclosur inform page report
